Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading

Main Article Content

Aaron Farberg
Jennifer Siegel
Sarah Kurley
Alison Fitzgerald
a:1:{s:5:"en_US";s:23:"Castle Biosciences Inc.";}

Anesh Prasai
Matthew Goldberg
Sherrif Ibrahim
Sarah Estrada

Keywords

risk assessment, cSCC, differentiation status, gene expression profile

References

1. Skincancer.org, 2022

2. Schmults, et al. JAMA Derm 2013

3. NCCN v2.2022

4. Thompson, et al. JAMA Derm 2016

5. Karia, et al. JCO 2014

6. Wysong, et al. JAAD 2021

7. Ibrahim, et al. Future Onc. 2021

8. Patel, et al. Cancer Medicine 2022

9. Jagdeo, et al. JAAD 2007

10. Prezzano, et al. Derm Surg 2021

Article Sidebar

Poster PDF
Published
Mar 13, 2023
DOI https://doi.org/10.25251/skin.7.supp.164

Article Details

How to Cite
[1]
Farberg, A., Siegel, J. , Kurley, S., Fitzgerald, A., Prasai, A., Goldberg, M., Ibrahim, S. and Estrada, S. 2023. Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s164. DOI:https://doi.org/10.25251/skin.7.supp.164.
Issue
Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Section
Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

<< < 1 2 3